Clinical Evidence Supporting FDA Clearance of First-of-a-Kind Therapeutic Devices via the De Novo Pathway Between 2011 and 2019 is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5K12HL138046-05
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases
National Institutes of Health
Grant: 5U01FD005938-04
Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI)
National Institutes of Health
Grant: 5R01HL144644-02
Leveraging Physician Networks to Improve Care and Outcomes for Low-Income Populations
National Institutes of Health
Grant: 1U01FD004585-01
Optimizing Medical Device Post-Market Surveillance for Public Value
National Institutes of Health
Grant: 1R01HS022882-01
Understanding hospital readmission rates: patient, hospital and community effects
National Institutes of Health
Grant: 5R01HS025164-04
Medical reversals: De-implementing ineffective and unsafe treatments
Fields of Study
Keywords
Sustainable Development Goals